188,533 Shares in Sabra Healthcare REIT, Inc. $SBRA Acquired by Uniplan Investment Counsel Inc.

Key Points

• Uniplan Investment Counsel Inc. has acquired a new position in Sabra Healthcare REIT, Inc., purchasing 188,533 shares valued at approximately $3,294,000, bringing its ownership to 0.08% of the company.
• Several institutional investors, including Hancock Whitney Corp and AQR Capital Management LLC, have also increased their stakes, indicating strong institutional interest in the stock.
• Analysts have raised their price targets for Sabra Healthcare REIT, with the average target now at $20.71 and an overall rating of "Moderate Buy."

Uniplan Investment Counsel Inc. purchased a new position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 188,533 shares of the real estate investment trust's stock, valued at approximately $3,294,000. Uniplan Investment Counsel Inc. owned approximately 0.08% of Sabra Healthcare REIT as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of the company. Hancock Whitney Corp raised its holdings in shares of Sabra Healthcare REIT by 1.9% during the first quarter. Hancock Whitney Corp now owns 209,923 shares of the real estate investment trust's stock valued at $3,667,000 after acquiring an additional 3,888 shares during the period. Alliancebernstein L.P. lifted its holdings in shares of Sabra Healthcare REIT by 5.7% in the first quarter. Alliancebernstein L.P. now owns 1,439,164 shares of the real estate investment trust's stock valued at $25,142,000 after purchasing an additional 78,090 shares in the last quarter. AQR Capital Management LLC grew its stake in Sabra Healthcare REIT by 12.1% during the 1st quarter. AQR Capital Management LLC now owns 1,370,813 shares of the real estate investment trust's stock valued at $23,948,000 after acquiring an additional 147,955 shares in the last quarter. Advisors Asset Management Inc. boosted its holdings in shares of Sabra Healthcare REIT by 10.6% during the first quarter. Advisors Asset Management Inc. now owns 176,877 shares of the real estate investment trust's stock worth $3,090,000 after purchasing an additional 16,886 shares during the period. Finally, Amundi grew its position in Sabra Healthcare REIT by 4.7% during the first quarter. Amundi now owns 143,389 shares of the real estate investment trust's stock valued at $2,531,000 after purchasing an additional 6,457 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on SBRA shares. Wells Fargo & Company lifted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research note on Wednesday, August 27th. Scotiabank increased their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a report on Monday, June 23rd. BMO Capital Markets lifted their price objective on Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a "market perform" rating in a research report on Monday, August 25th. Truist Financial raised their price objective on Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a "hold" rating in a research note on Tuesday, September 2nd. Finally, JMP Securities raised their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a report on Wednesday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, Sabra Healthcare REIT has a consensus rating of "Moderate Buy" and a consensus target price of $20.71.

Sabra Healthcare REIT Stock Down 0.1%

Shares of NASDAQ SBRA traded down $0.02 during trading hours on Friday, hitting $19.12. The company had a trading volume of 489,066 shares, compared to its average volume of 2,430,979. The stock has a market capitalization of $4.58 billion, a P/E ratio of 25.15, a price-to-earnings-growth ratio of 1.51 and a beta of 0.88. The firm's 50 day moving average is $18.68 and its 200-day moving average is $17.95. Sabra Healthcare REIT, Inc. has a 1-year low of $15.60 and a 1-year high of $20.03. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. The company had revenue of $189.15 million during the quarter, compared to analysts' expectations of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. Sabra Healthcare REIT's quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 6.3%. Sabra Healthcare REIT's payout ratio is 157.89%.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.